Normalization of the tumor vasculature can affect HIF1α/VEGFa feedback and reduce TC recruitment or vasculogenic mimicry (VM) formation, leading to better clinical responses in cancer patients [39, 40]. This evidence concerns the gene HIF1A and cancer.